Ex-Genentech star and 23andMe vet Richard Scheller jumps to newly public unicorn biotech BridgeBio as ‘chairman of R&D’
So what exactly is a chairman of R&D?
We found out this evening — courtesy of a connection made at STAT — that star scientist Richard Scheller, who made his bones as head of R&D at the star-spangled Genentech, now holds that lofty title at the newly public BridgeBio $BBIO, a newfangled biotech umbrella group run by Neil Kumar.
Basic subscription required
Unlock this story instantly and join 55,100+ biopharma pros reading Endpoints daily — and it's free.